THYMIC CANCER

Clinical trials for THYMIC CANCER explained in plain language.

Never miss a new study

Get alerted when new THYMIC CANCER trials appear

Sign up with your email to follow new studies for THYMIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Terminated 1

New hope for rare thymus cancers: experimental drug shows promise

Disease control Ongoing

This study tests a drug called bintrafusp alfa (M7824) in people with thymoma or thymic carcinoma that returned after standard platinum chemotherapy. The goal is to see if the drug can shrink tumors or slow disease progression. Participants receive the drug by IV every two weeks …

Matched conditions: THYMIC CANCER

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 14, 2026 12:11 UTC

THYMIC CANCER

Get alerted when new THYMIC CANCER trials appear

New hope for rare thymus cancers: experimental drug shows promise